Asset Allocation

As of June 30, 2026.
Type % Net
Cash 3.26%
Stock 65.16%
Bond 30.56%
Convertible 0.00%
Preferred 0.00%
Other 1.02%
View Asset Allocation
Start Trial

Market Capitalization

As of June 30, 2026
Large 85.90%
Mid 10.40%
Small 3.70%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.82%    % Emerging Markets: 0.13%    % Unidentified Markets: 1.05%

Americas 80.19%
79.66%
Canada 42.84%
United States 36.82%
0.53%
Mexico 0.05%
As of June 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 16.71%
United Kingdom 4.62%
11.50%
Belgium 1.13%
Denmark 0.00%
France 0.92%
Germany 2.55%
Ireland 1.32%
Italy 0.59%
Netherlands 2.21%
Switzerland 2.75%
0.00%
0.59%
Israel 0.59%
Greater Asia 2.04%
Japan 2.04%
0.00%
Australia 0.00%
0.00%
Hong Kong 0.00%
Singapore 0.00%
0.00%
Unidentified Region 1.05%

Bond Credit Quality Exposure

AAA 18.41%
AA 11.31%
A 16.22%
BBB 30.78%
BB 9.80%
B 5.17%
Below B 0.20%
    CCC 0.20%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.35%
Not Available 7.76%
Short Term 0.00%
As of June 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
34.29%
Materials
4.62%
Consumer Discretionary
4.18%
Financials
21.55%
Real Estate
3.94%
Sensitive
41.69%
Communication Services
3.82%
Energy
2.74%
Industrials
17.14%
Information Technology
17.99%
Defensive
21.12%
Consumer Staples
7.89%
Health Care
10.86%
Utilities
2.37%
Not Classified
2.90%
Non Classified Equity
2.90%
As of June 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of June 30, 2026
Type % Net
Government 11.84%
Corporate 65.05%
Securitized 0.98%
Municipal 15.61%
Other 6.52%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
1.08%
Less than 1 Year
1.08%
Intermediate
68.51%
1 to 3 Years
10.57%
3 to 5 Years
14.68%
5 to 10 Years
43.26%
Long Term
29.46%
10 to 20 Years
3.66%
20 to 30 Years
16.78%
Over 30 Years
9.02%
Other
0.94%
As of June 30, 2026
View Bond Maturity Exposure
Start Trial